The “metabolic syndrome index”: A novel, comprehensive method for evaluating the efficacy of diabetes prevention programs


A myriad of diabetes prevention programs are carried out worldwide to fight against the current type 2 diabetes (T2D) pandemic. The lack of a unified criterion for evaluating the efficacy of T2D prevention programs, however, makes the interpretation of prevention program results difficult, and hinders clear and direct comparisons of different prevention programs. Metabolic syndrome is a strong indicator for diabetes and its complications, holding great promise to become the basis of an intervention evaluation method. The Metabolic Syndrome Index (MSI), proposed here, quantifies the metabolic risk for developing T2D and its complications. The MSI is a novel scale for evaluating the efficacy of diabetes prevention programs because it is a systematic, comprehensive, and stable indicator that reflects the metabolic risk reduction for diabetes and its complications at multiple levels and dimensions.

Share and Cite:

Jin, H. and Benyshek, D. (2013) The “metabolic syndrome index”: A novel, comprehensive method for evaluating the efficacy of diabetes prevention programs. Journal of Diabetes Mellitus, 3, 96-99. doi: 10.4236/jdm.2013.32014.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Fleiss, J.L., Levin, B. and Cho Paik, M. (2003) Statistical methods for rates and proportions. 3rd Edition, WileyInterscience, Hoboken.
[2] Hamman, R.F., Wing, R.R., Edelstein, S.L., Lachin, J.M., Bray, G.A., Delahanty, L.D. and Hoskin, A.M. (2006) Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care, 42, 2102-2107. doi:10.2337/dc06-0560
[3] Ali, M.K., Echouffo-Tcheugui, J. and Williamson, D.F. (2012) How effective were lifestyle interventions in realworld settings that were modeled on the Diabetes Prevention Program? Health Affairs, 31, 67-75. doi:10.1377/hlthaff.2011.1009
[4] Feller, S., Boeing, H. and Pischon, T. (2010) Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: Implications for routine clinical practice. Deutsches?rzteblatt International, 107, 470-476. doi:10.3238/arztebl.2010.0470
[5] Pan, X.R., Li, G.W., Hu, Y.H., Wang, J.X., Yang, W.Y., An, Z.X. and Hu, Z.X. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care, 20, 537-544. doi:10.2337/diacare.20.4.537
[6] Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamlainen, H., Ilanne-Parikka, P. and Keinanen-Kiukaanniemi, S. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine, 344, 1343-1350. doi:10.1056/NEJM200105033441801
[7] Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A.D. and Vijay, V. (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49, 289-297. doi:10.1007/s00125-005-0097-z
[8] Lorenzo, C., Okoloise, M., Williams, K., Stern, M.P. and Haffner, S.M. (2003) The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care, 26, 3153-3159. doi:10.2337/diacare.26.11.3153
[9] Grundy, S.M., Brewer, B.H., Cleeman, J.I., Smith, S.C. and Lenfant, C. (2004) Definition of metabolic syndrome, report of the National Heart, Lung, and Blood Institute/ American Heart Association Conference on Scientific Issues Related to Definition. Circulation, 109, 433-438. doi:10.1161/01.CIR. 0000111245.75752.C6
[10] Alberti, K.G. and Zimmet, P.Z. (1998) Definition, diagnosis and classification ofdiabetes mellitus and its complications, part 1: Diagnosis and classificationof diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
[11] Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A. and Gordon, D.J. (2005) Diagnosis and management of the metabolic syndrome, an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Critical Pathways in Car diology, 4, 198-203.
[12] Wilson, P.W.F., D’Agostino, R.B., Parise, H., Sullivan, L. and Meigs, J.B. (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes. Circulation, 112, 3066-3072.
[13] Christ, M., Iannello, C., Iannello, P.G. and Grimm, W. (2004) Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome. International Journal of Cardiology, 97, 115-122.
[14] Orchard, T.J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S. and Fowler, S. (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The diabetes prevention program randomized trial. Annuals of Internal Medicine, 142, 611-619. doi:10.7326/0003-4819-142-8-200504190-00009
[15] Okura, T., Nakata, Y., Ohkawara, K., Numao, S., Katayama, Y., Matsuo, T. and Tanaka, K. (2007) Effects of aerobic exercise on metabolic syndrome improvement in response to weight reduction. Obesity, 15, 2478-2484. doi:10.1038/oby.2007.294
[16] Muzio, F., Mondazzi, L., Harris, W.S., Sommariva, D. andBranchi, A. (2007) Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. The American Journal of Clinical Nutrition, 86, 946-951.
[17] Meckling, K.A. and Sherfey, R. (2007) A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the metabolic syndrome in overweight and obese women. Applied Physiology, Nutrition, and Metabolism, 32, 743-752. doi:10.1139/H07-059
[18] Rector, R.S., Warner, S.O., Liu, Y., Hinton, P.S., Sun, G.Y., Cox, R.H. and Stump, C.S. (2007) Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. American Journal of Physiology, Endocrinal Metabolism, 293, E500-E506. doi:10.1152/ajpendo.00116.2007

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.